THE DECADE OF THE KIDNEY™ – WILL YOU ANSWER THE CALL?

Sidhvi Nekkanti
By Edward V. Hickey III, AAKP Board of Director, Secretary and Chair of Veterans Health Initiative, and Paul T. Conway, AAKP Board of Director, Chair, Policy & Global Affairs It is not every day that you, as a patient advocate, are asked to make and engage in a 10 year commitment – but today is the day!
Read More

School Days: An Interview

Admin
By Jim Myers, AAKP Board of Director and Ambassador In honor of school days, we are writing today about 5-year-old Henry Whitacre and his mom, Emily. Henry received a kidney transplant at Riley's Children's Hospital in Indianapolis, Indiana on July 18th, 2018.
Read More

August 14 is Global Yoga Therapy Day

Admin
By Tish Ganey, 500 RYT (registered yoga teacher) and teacher of Advanced Therapeutic Yoga “If you can breathe, you can do yoga!” That is the slogan of this year’s Global Yoga Therapy Day celebrated on August 14. It highlights the fact that yoga is something you can practice anywhere, anytime.
Read More

PROFESSIONAL PROFILE: Doris Harrison, RN CKD/Transplant Specialist

Sidhvi Nekkanti
By: Doris Harrison, RN CKD/Transplant Specialist Approximately 14 years ago, I began my career in the medical field working within a kidney transplant clinic as a medical assistant. At first, I was not sure if this was where I would stay, I was hoping to work in the hospital with newborn babies, but God had another plan for me.
Read More

AAKP 2019 National Patient Meeting – Meet the Planning Committee: Renee Bova-Collis

Sidhvi Nekkanti
By Trevor Wymer, AAKP Communications Intern Renee Bova-Collis has worked in the field of kidney disease since 1993. As the Patient Services Director at Quality Insights Renal Network 5, Renee is a Social Worker who directly talks to patients offering resources and assistance. Renee was on the AAKP Board of Directors from 2006-2013.
Read More

AAKP Innovator Series: AstraZeneca, Kerry Cooper, Vice President, U.S. Medical Affairs, Renal Cardio

Sidhvi Nekkanti
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology; Cardiovascular, Renal & Metabolism; and Respiratory.
Read More